Global Epinephrine Auto-Injector Market, By Product Type (Type 0.30 mg, 0.15 mg), Application (Under 6 Years, 6 to 12 Years, Over 12 Years), End-User (Hospitals, Clinics, Individuals) – Industry Trends and Forecast to 2029.
Epinephrine Auto-Injector Market Analysis and Size
People with severe allergies utilize hand-held medical devices called epinephrine auto-injectors. Epinephrine injections are frequently used to treat allergies that can be fatal and are brought on by stings, bug bites, or medications. Adrenaline injections are administered using automated prefilled injectable devices that are prefilled with liquid epinephrine. A single-use, disposable, spring-loaded syringe is the most typical kind of auto-injector. Due to its design, it is easy to use and can be administered by unskilled staff members or patients.
Data Bridge Market Research analyses that the epinephrine auto-injector market which was USD 1.88 billion in 2021, would rocket up to USD 3.56 billion by 2029, and is expected to undergo a CAGR of 8.30% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Epinephrine Auto-Injector Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Type 0.30 mg, 0.15 mg), Application (Under 6 Years, 6 to 12 Years, Over 12 Years), End-User (Hospitals, Clinics, Individuals)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
|
|
Market Opportunities
|
|
Market Definition
Epinephrine also known as adrenaline, is a hormone released from adrenal glands to treat allergic reactions. An auto-injector for epinephrine or adrenaline is a medical tool used to treat anaphylaxis. They are sold as pre-filled auto injecting devices that include the medication to be injected under the skin or into the muscles.
Epinephrine Auto-Injector Market Dynamic
Drivers
- Rise in allergies
As the prevalence of allergies rises related to food additives, dust and latex, so demand of auto-injectors, propelling the global market for epinephrine auto-injector forward.
- Technological developments
The epinephrine auto-injector market's growth is fueled by factors including increased awareness of allergies, technological developments in research and development (R&D) activities, and chlorofluorocarbon-free auto-injector inhalers using hydrofluoroalkane propellants, and a high demand for auto-injectors rather than more conventional devices like standard epinephrine.
- Increasing incidence of anaphylaxis
One of the main factors propelling the epinephrine market's rise is the rising prevalence of anaphylaxis. A major allergic reaction called anaphylaxis, which can be fatal, can happen minutes after being exposed to an allergen. Anaphylaxis affects roughly 1 in 50 persons in the UK annually, and this figure is rising, per an Allergy UK research. In the upcoming years, it is anticipated that the rising allergy rate would increase demand for epinephrine-based medicines.
Opportunities
Due to the rise in patients with allergies to dust, food, food additives, insect stings, and venom, the market has expanded. The fact that these auto-injectors are crucial for treating anaphylaxis and enable non-medical people to successfully treat the condition will probably lead to an increase in demand for epinephrine auto-injectors globally.
Restraints/Challenges
On the other hand, the regulatory barriers and expensive expenses will obstruct the market's growth rate.
This epinephrine auto-injector market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the epinephrine auto-injector market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Epinephrine Auto-Injector Market
The COVID-19 had an impact on the world economy by directly altering supply and demand, disrupting the supply chain and the market, and having an economic impact on businesses and financial markets. Most nations have lifted their lockdown laws, but because people are worried about the coronavirus, they avoid going to the doctor in person (COVID-19). As a result, businesses in the epinephrine auto-injector market are using telemedicine since people in the COVID-19 era demand remote healthcare services. Over the course of the forecast period, telehealth technology demand is anticipated to soar significantly.
Global Epinephrine Auto-Injector Market Scope
The epinephrine auto-injector market is segmented on the basis of type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- 0.30 mg
- 0.15 mg
Application
- Under 6 Years
- 6 to 12 Years
- Over 12 Years
End-User
Epinephrine Auto-Injector Market Regional Analysis/Insights
The epinephrine auto-injector market is analysed and market size insights and trends are provided by country, type, application and end-user as referenced above.
The countries covered in the epinephrine auto-injector market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the epinephrine auto-injector market due to the growing number of geriatric population along with adoption of innovative medical technology.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and growing demand of advanced medical technology.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Epinephrine Auto-Injector Market Share Analysis
The epinephrine auto-injector market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to epinephrine auto-injector market.
Some of the major players operating in the epinephrine auto-injector market are:
- Adamis Pharmaceuticals Corporation (U.S.)
- ALK (Denmark)
- Antares Pharma (U.S.)
- Bausch + Lomb Incorporated (U.K.)
- Hospira, Inc. (U.S.)
- Impax Laboratories, Inc. (U.S.)
- Lincoln Medical (U.S.)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Impax (U.S.)
- Pfizer Inc. (U.S.)
- Amphastar Pharmaceuticals, Inc. (U.S.)
- Emerade (U.S.)
- Grand Pharma Group Limited (Hong Kong)
- Harvest Pharmaceuticals (U.S.)
- Merit Healthcare International Inc. (U.S.)
- Tianjin Jinyao Group (China)
SKU-